Hedgefund Douche Buys Rights to AIDS Drug, Raises Price from $13.50 to $750
The AIDS drug Daraprim costs about $1 to make, and used to cost just $13.50 per tablet. That is until the price was jacked up overnight to $750 a pill — a 5,500 percent increase.
The gigantic price hike happened after Martin Shkreli’s company Turing Pharmaceuticals purchased the rights to the life-saving drug back in August. When the company entered a near-apocalyptic firestorm, journalist John Carroll asked the CEO for a statement.
The businessman responded to the inquiry in about a minute, bluntly saying, “It's a great business decision that also benefits all of our stakeholders. I don't expect the likes of you to process that.”
We guess the 32-year-old didn’t have to run that by his PR people? Or maybe he didn’t care because he then called the biotech writer “such a moron” and proceeded to quote Eminem’s “The Way I Am.”
Turing’s No. 1 guy told CBS a similarly bottom-line savvy story, saying, “the drug was unprofitable at the former price, so any company selling it would be losing money. And at this price it's a reasonable profit. Not excessive at all."
But now Martin is trying to change his story from corporate schemer to humanitarian.
On Twitter he’s promised to “announce some adjustments” to the original plan and can “guarantee better access at lower prices to patients than ever.”
The CEO also reportedly wants to use use the drug to target tropical diseases.
Let’s just hope the real victims here — Daraprim users — get to keep using their medicine.